[
    {
        "question": "Prokinetic drug with extrapyramidal side effect is?",
        "exp": "Ans. (d) Metoclopramide. Ref KDT 6/e, p 642",
        "cop": 4,
        "opa": "Cisapride",
        "opb": "Domperidone",
        "opc": "Ondansetron",
        "opd": "Metoclopramide",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "eff72e53-a976-4e2e-a0d3-66810e8b93e1",
        "choice_type": "single"
    },
    {
        "question": "Which of the following drugs is not an antiemetic?",
        "exp": "Ans. (D) Cinnarizine(Ref: KDT, 18th/e p712). Cinnarizine is an anti-vertigo drug. Metoclopramide and domperidone are antiemetic drugs. These act by blocking D2 receptors. Ondansetron is an antagonist of 5. HT3 receptors. It is the drug of choice for chemotherapy induced vomiting.",
        "cop": 4,
        "opa": "Ondansetron",
        "opb": "Domperidone",
        "opc": "Metoclopramide",
        "opd": "Cinnarizine",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "b917bdad-2e72-40d1-9447-e0b7de35e8bb",
        "choice_type": "single"
    },
    {
        "question": "Drug implicated in prolonging QT interval is:",
        "exp": "Ans. (C) Cisapride(Ref: KDT 8th/e p715). Cisapride is a 5. HT4 agonist that is useful as a prokinetic agent. At high plasma concentration, it can block cardiac K+ channels leading to polymorphic ventricular tachycardia (torsades de pointes). It is manifested in the ECG as QT prolongation. Therefore, cisapride should not be combined with microsomal enzyme inhibitors like erythromycin and ketoconazole. Other important drugs causing QT prolongation are. Terfenadine. Astemizole. Ziprasidone",
        "cop": 3,
        "opa": "Domperidone",
        "opb": "Metoclopramide",
        "opc": "Cisapride",
        "opd": "Omeprazole",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "6b09d598-694d-46db-8706-3f406f3974d5",
        "choice_type": "single"
    },
    {
        "question": "Cisapride was withdrawn from market due to?",
        "exp": "ANSWER: (A) QT Prolongation. REF: Lippincott's 4th ed ch: 17. See previous question for list of drugs causing QT prolongation. Inhibition of potassium channels widens the action potential, leading to a prolonged QT interval on the electrocardiogram. Such an effect is associated with increased risk of developing life-threatening ventricular tachyarrhythmias (torsades de pointes). The most common cause of QT prolongation is drug-induced, although it may also be genetic.",
        "cop": 1,
        "opa": "QT Prolongation",
        "opb": "Increased PR interval",
        "opc": "Teratogenicity",
        "opd": "Myocardial damage",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "af05e3ef-7e1b-4fa9-9378-abaf41dced8c",
        "choice_type": "single"
    },
    {
        "question": "Drug given for metoclopramide induced dystonic reaction is:",
        "exp": "Ans. (B) Promethazine(Ref: KDT 8th/e p180)\"Acute muscle dystonia caused by antiemetic-antipsychotic drugs is promptly relieved by parenteral promethazine or hydroxyzine\" This is based on central anti-cholinergic action of the drugs. Promethazine is a first generation anti-histaminic which has maximum penetration of blood brain barrier and maximum anticholinergic activity.",
        "cop": 2,
        "opa": "Pheniramine",
        "opb": "Promethazine",
        "opc": "Chlorpromazine",
        "opd": "Prochlorperazine",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "88c6edee-5d11-48aa-ab60-eaf2b6b9f239",
        "choice_type": "single"
    },
    {
        "question": "NK receptor antagonist that prevents vomiting -",
        "exp": "Ans. is 'd' i. e., Aprepitant Aprepitanto Aprepitant is an antiemetic substance that belongs to a class of drugs called substance P antagonists, o The compound mediates its effect by blocking the neurokinim 1 (NK1) receptor. o Certain regions of brain have high expression of NK1 receptors. Substance P acts on these receptors and is responsible for chemotheraphy induced nausea and vomiting. Aprepitant acts as a substance P antagonist on NK1 receptors. o Aprepitant has little or no affinity for Serotonin 5-HT3, dopamine or corticosteroid receptors, o Aprepitant crosses the blood brain barrier. o Aprepitant is used for chemotherapy induced nausea & vomiting (CINV), and post- operative nausea & vomiting (PONV). o After absorption aprepitant is bound extensively to plasma proteins (>95%); it is metabolized avidly, primarily by hepatic CYP 5. A4 and is excreted in the stools. o Aprepitant is contraindicated in patients on cisapride or pimozide, in which life threatening QT prolongation has been reported. o The recommended adult dose of a prepitant is 125 mg administered 1 hour before chemotherapy on day one, followed by 8 mg once daily in the morning on day 2 and 3 of the treatment regimen.",
        "cop": 4,
        "opa": "Bosutran",
        "opb": "Gramisetron",
        "opc": "Ondansetran",
        "opd": "Aprepitant",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "ddea6372-f5da-4be8-9a15-d595a9be113c",
        "choice_type": "single"
    },
    {
        "question": "Antiemetic effect of metoclopramide is mainly due to its action as:",
        "exp": "Ans. (B) D2 antagonist(Ref: Katzung 13th/1070, KDT 8th/e p713). Metoclopramide has action on several receptors. Main action as anti-emetic is because of D2 receptor antagonism. Main action as prokinetic is because of 5. HT4 agonism. Mechanism of actions of metoclopramide. Receptor. Action. Clinical effect. D2. Antagonism. Anti-emetic5. HT3. Antagonism. Anti-emetic. Prokinetic5. HT4. Agonism. Prokinetic",
        "cop": 2,
        "opa": "5. HT3 antagonist",
        "opb": "D2 antagonist",
        "opc": "M3 antagonist",
        "opd": "5. HT4 agonist",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "c913763e-44f1-41d8-9455-a2b6f11bf990",
        "choice_type": "single"
    },
    {
        "question": "A person has to go to Shimla next morning. What drug should be given to prevent motion sickness in this person?",
        "exp": "Ans. (A) Scopolamine patch a night before(Ref: KDT 7/e p120). Scopolamine (hyoscine) is drug of choice for motion sickness. It should be given as transdermal patch (a night before) or orally (half an hour before journey).",
        "cop": 1,
        "opa": "Scopolamine patch a night before",
        "opb": "Ranitidine one night before and then before the trip",
        "opc": "Dimenhydrinate 1 hour before journey",
        "opd": "Omeprazole half an hour before the trip",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "6f3deba1-959c-4f0d-963b-151010e101a1",
        "choice_type": "single"
    },
    {
        "question": "An anti-emetic drug that also decreases acid secretion due to its action on H1 receptors is:",
        "exp": "Ans. (A) Promethazine(Ref: Katzung 11/e p277). Promethazine is a first generation H1 -antihistaminic drug. It is indicated for treatment of allergic reactions. Because of its anticholinegic action and ability to cross blood brain barrier, it can be used as an antiemetic (particularly for prophylaxis of motion sickness) and as an anti-Parkinsonian drug (particularly in drug induced Parkinsonism). Acid secretion is reduced mainly by H2 -blocking drugs like ranitidine but even H1 -anti histaminics can also reduce acid secretion at high doses (due to lack of selectivity at such high dose).",
        "cop": 1,
        "opa": "Promethazine",
        "opb": "Domperidone",
        "opc": "Metoclopramide",
        "opd": "Ondansetron",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "56cc05b7-1374-4acd-b8f0-235df39cc479",
        "choice_type": "single"
    },
    {
        "question": "All are antiemetic except -",
        "exp": "Ans. is 'd' i. e., Bismuth Antiemetic drugs. Anticholinergics - Hyoscine, Dicyclomine. Ht antihistaminics Promethazine, cyclizine, Cinnarizine, etc. Neuroleptics (D2 blockers) - Chlorpromazine, Haloperidol, Droperidole etc. Prokinetics drugs - Metoclopramide, Domperidone, cisapride, Mosapride, Tegaserod. 5-HT3 antagonists - Ondansetron, Granisetron. Adjuvant antiemetics - Dexamethasone, BZDs, Cannabinoids, Clonidine & ephedrine.",
        "cop": 4,
        "opa": "Ondansetran",
        "opb": "Metoclopramide",
        "opc": "Chlorpromazine",
        "opd": "Bismuth",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "3068b0b0-910e-4d59-a1ee-9162a02049fc",
        "choice_type": "multi"
    },
    {
        "question": "Which of the following is a pro kinetic drug-",
        "exp": "Ans. is 'a' i. e., Domperidone Gastrokinetk (prokinetic drugs)o These are the drugs which promote gastrointestinal transit and speed gastric emptying by enhancing coordinated propulsive motility. o Prokinetic drugs are - Metoclopramide, Domperidone, Cisapride, Mosapride, Tegaserod, renzapride, prucatopride. Pathophysiology of gastrokinetic drugs: o Acetylcholine is the major neurotransmitter in the GIT which is responsible for the peristaltic movement, o Its secretion is affected by other neurotransmitter also -1. Activation of prejunctional excitatory 5-HT, receptors increases the release of Ach. 2. Activation of prejunctional inhibitory D2 and 5-HT. receptors inhibits the release of Ach. o So, prokinetic drugs can act by -1. 5. HT4 agonistic activity2. D2 and 5-HT3 antagonistic activityo Both these action will increase the release of Ach and there by motility of GIT.",
        "cop": 1,
        "opa": "Domperidone",
        "opb": "Cimetidine",
        "opc": "Ondansetron",
        "opd": "Hyoscine",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "f3d4aa07-91fd-43eb-a8c0-cac1b37543e1",
        "choice_type": "single"
    },
    {
        "question": "Metoclopramide:",
        "exp": "Ans. (D) Enhances colonic motility(Ref: Katzung 10/e p1021; KDT 8th/e p713). Metoclopramide is a D2 receptor antagonist that increases cholinergic activity by inhibiting presynpatic D2 receptors in GIT (D2 receptor stimulation inhibits the release of ACh). It increase LES tone that is also responsible for anti-emetic action. It does not significantly increase colonic motility. But out of the four options, this is the best answer, because although not significantly but it can increase colonic motility, whereas other options are definitely wrong.",
        "cop": 4,
        "opa": "Inhibit cholinergic smooth muscle stimulation in the gastrointestinal tract",
        "opb": "Decrease lower esophageal sphincter pressure",
        "opc": "Stimulate D2 receptor",
        "opd": "Enhance colonic motility",
        "subject_name": "Pharmacology",
        "topic_name": "Anti-Emetic",
        "id": "98d556ee-b095-4729-8e72-234312ef1581",
        "choice_type": "single"
    }
]